Clinical trials recruiting in Roskilde, Denmark

Phase breakdown

Conditions recruiting in Roskilde, Denmark

Recruiting trials in Roskilde, Denmark

• A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
  NCT06642272 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
  NCT06793215 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
  NCT06119581 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  NCT04928846 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
  NCT07522073 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female)
• A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
  NCT07144280 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Assessment of Residual Congestion in Acute Decompensated Heart Failure
  NCT07682298 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
  NCT07195695 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
  NCT05889247 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
  NCT06892210 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female)
• DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure
  NCT05276219 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Danish Evaluation of Early Catheter Ablation for Atrial Fibrillation in Patients With Heart Failure
  NCT06560047 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
  NCT03730922 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
  NCT04916132 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis
  NCT07304375 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
  NCT03994471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Immunotherapy in Patients With Early dMMR Rectal Cancer
  NCT05732389 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients
  NCT05053997 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)
  NCT07569458 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
  NCT06166654 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)
  NCT06938971 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
  NCT04095299 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study on the Effect of 40 Hz Non-Invasive Light Therapy System
  NCT05260177 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female)
• TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
  NCT07716969 · Phase: Not specified · Ages: 18 Years to 35 Years · Sex: All (male and female)
• The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
  NCT07077447 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
  NCT03862859 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
  NCT04330729 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female)
• The Post-ICU Pain Study
  NCT07180407 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Virtual Reality to Reduce Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy
  NCT06616324 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• When to INDuce for OverWeight? (WINDOW)
  NCT04603859 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Roskilde, Denmark?

37 recruiting trials have at least one study site in Roskilde, Denmark.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.